{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:23:37Z","timestamp":1791829417950,"version":"4.3.4"},"reference-count":248,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Cancer and cardiovascular diseases (CVD) often share common risk factors, and patients with CVD who develop cancer are at high risk of experiencing major adverse cardiovascular events. Additionally, cancer treatment can induce short- and long-term adverse cardiovascular events. Given the improvement in oncological patients\u2019 prognosis, the burden in this vulnerable population is slowly shifting towards increased cardiovascular mortality. Consequently, the field of cardio-oncology is steadily expanding, prompting the need for new markers to stratify and monitor the cardiovascular risk in oncological patients before, during, and after the completion of treatment. Advanced non-invasive cardiac imaging has raised great interest in the early detection of CVD and cardiotoxicity in oncological patients. Nuclear medicine has long been a pivotal exam to robustly assess and monitor the cardiac function of patients undergoing potentially cardiotoxic chemotherapies. In addition, recent radiotracers have shown great interest in the early detection of cancer-treatment-related cardiotoxicity. In this review, we summarize the current and emerging nuclear cardiology tools that can help identify cardiotoxicity and assess the cardiovascular risk in patients undergoing cancer treatments and discuss the specific role of nuclear cardiology alongside other non-invasive imaging techniques.<\/jats:p>","DOI":"10.1093\/ehjci\/jead168","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:56:52Z","timestamp":1689814612000},"page":"1129-1145","source":"Crossref","is-referenced-by-count":13,"title":["Tales from the future\u2014nuclear cardio-oncology, from prediction to diagnosis and monitoring"],"prefix":"10.1093","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4896-1428","authenticated-orcid":false,"given":"Nidaa","family":"Mikail","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich , R\u00e4mistrasse 100, 8091 Zurich , Switzerland"},{"name":"Center for Molecular Cardiology, University of Zurich , Wagistrasse 12, 8952 Schlieren , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Chequer","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Bichat University Hospital, AP-HP, University Diderot , 75018 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Imperiale","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, Institut de Canc\u00e9rologie de Strasbourg Europe (ICANS), University Hospitals of Strasbourg , 67093 Strasbourg , France"},{"name":"Molecular Imaging-DRHIM, IPHC, UMR 7178, CNRS\/Unistra , 67093 Strasbourg , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Meisel","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich , R\u00e4mistrasse 100, 8091 Zurich , Switzerland"},{"name":"Kantonsspital Glarus , Burgstrasse 99, 8750 Glarus , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2424-3894","authenticated-orcid":false,"given":"Susan","family":"Bengs","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich , R\u00e4mistrasse 100, 8091 Zurich , Switzerland"},{"name":"Center for Molecular Cardiology, University of Zurich , Wagistrasse 12, 8952 Schlieren , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Portmann","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich , R\u00e4mistrasse 100, 8091 Zurich , Switzerland"},{"name":"Center for Molecular Cardiology, University of Zurich , Wagistrasse 12, 8952 Schlieren , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3378-1723","authenticated-orcid":false,"given":"Alessia","family":"Gimelli","sequence":"additional","affiliation":[{"name":"Imaging Department, Fondazione CNR\/Regione Toscana Gabriele Monasterio , Via G. Moruzzi 1, 56124 Pisa , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny R","family":"Buechel","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich , R\u00e4mistrasse 100, 8091 Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cath\u00e9rine","family":"Gebhard","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich , R\u00e4mistrasse 100, 8091 Zurich , Switzerland"},{"name":"Center for Molecular Cardiology, University of Zurich , Wagistrasse 12, 8952 Schlieren , Switzerland"},{"name":"Department of Cardiology, University Hospital Inselspital Bern , Freiburgstrasse 18, 3010 Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Rossi","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich , R\u00e4mistrasse 100, 8091 Zurich , Switzerland"},{"name":"Center for Molecular Cardiology, University of Zurich , Wagistrasse 12, 8952 Schlieren , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,19]]},"reference":[{"key":"2023091415161399000_jead168-B1"},{"key":"2023091415161399000_jead168-B2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.atherosclerosis.2017.06.001","article-title":"Cardiovascular disease and cancer: evidence for shared disease pathways and pharmacologic prevention","volume":"263","author":"Masoudkabir","year":"2017","journal-title":"Atherosclerosis"},{"key":"2023091415161399000_jead168-B3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/CIRCULATIONAHA.118.035516","article-title":"Synergistic opportunities in the interplay between cancer screening and cardiovascular disease risk assessment: together we are stronger","volume":"138","author":"Handy","year":"2018","journal-title":"Circulation"},{"key":"2023091415161399000_jead168-B4","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cjca.2016.04.008","article-title":"Shared risk factors for cardiovascular disease and cancer: implications for preventive health and clinical care in oncology patients","volume":"32","author":"Johnson","year":"2016","journal-title":"Can J Cardiol"},{"key":"2023091415161399000_jead168-B5","doi-asserted-by":"crossref","first-page":"e0247919","DOI":"10.1371\/journal.pone.0247919","article-title":"Ten-year cardiovascular risk among cancer survivors: the National Health and Nutrition Examination Survey","volume":"16","author":"Zhang","year":"2021","journal-title":"PloS One"},{"key":"2023091415161399000_jead168-B6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaccao.2020.12.003","article-title":"Cardiovascular risk factors are associated with future cancer","volume":"3","author":"Lau","year":"2021","journal-title":"JACC CardioOncol"},{"key":"2023091415161399000_jead168-B7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaccao.2020.07.001","article-title":"Prediction of lifetime and 10-year risk of cancer in individual patients with established cardiovascular disease","volume":"2","author":"van \u2018t Klooster","year":"2020","journal-title":"JACC CardioOncol"},{"key":"2023091415161399000_jead168-B8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ejhf.654","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"19","author":"Zamorano","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2023091415161399000_jead168-B9","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.jacc.2019.03.500","article-title":"Cardiac radiation dose, cardiac disease, and mortality in patients with lung cancer","volume":"73","author":"Atkins","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B10","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","article-title":"A population-based study of cardiovascular disease mortality risk in US cancer patients","volume":"40","author":"Sturgeon","year":"2019","journal-title":"Eur Heart J"},{"key":"2023091415161399000_jead168-B11","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"2023091415161399000_jead168-B12","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/ehf2.12551","article-title":"Recent advances in cardio-oncology: a report from the \u2018Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019\u2019","volume":"6","author":"Anker","year":"2019","journal-title":"ESC Heart Fail"},{"key":"2023091415161399000_jead168-B13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol"},{"key":"2023091415161399000_jead168-B14","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/ejhf.1957","article-title":"Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)","volume":"22","author":"\u010celutkien\u0117","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2023091415161399000_jead168-B15","doi-asserted-by":"crossref","first-page":"e011857","DOI":"10.1161\/CIRCIMAGING.120.011857","article-title":"Early diagnosis and treatment of myocardial neuroendocrine tumor metastasis: the cornerstone role of multimodality imaging","volume":"14","author":"Mikail","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B16","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1007\/s00259-022-05709-9","article-title":"Diagnosis and staging of cardiac masses: additional value of CMR with (18)F-FDG-PET compared to CMR with CECT","volume":"49","author":"Mikail","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023091415161399000_jead168-B17","first-page":"24","article-title":"A new classification of cardio-oncology syndromes","volume":"7","author":"de Boer","year":"2021","journal-title":"Cardiooncology"},{"key":"2023091415161399000_jead168-B18","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/cvr\/cvaa222","article-title":"Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart","volume":"116","author":"Tocchetti","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2023091415161399000_jead168-B19","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"2023091415161399000_jead168-B20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/cvr\/cvz035","article-title":"Common risk factors for heart failure and cancer","volume":"115","author":"Meijers","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2023091415161399000_jead168-B21","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: a consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"2023091415161399000_jead168-B22","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1161\/HYPERTENSIONAHA.111.189258","article-title":"Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project","volume":"59","author":"Stocks","year":"2012","journal-title":"Hypertension"},{"key":"2023091415161399000_jead168-B23","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1001\/jama.294.12.1505","article-title":"Effect of smoking reduction on lung cancer risk","volume":"294","author":"Godtfredsen","year":"2005","journal-title":"JAMA"},{"key":"2023091415161399000_jead168-B24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women","volume":"306","author":"Freedman","year":"2011","journal-title":"JAMA"},{"key":"2023091415161399000_jead168-B25","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer\u2014viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"key":"2023091415161399000_jead168-B26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yjmcc.2022.03.010","article-title":"Genetics of cancer therapy-associated cardiotoxicity","volume":"167","author":"Kim","year":"2022","journal-title":"J Mol Cell Cardiol"},{"key":"2023091415161399000_jead168-B27","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"key":"2023091415161399000_jead168-B28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCRESAHA.117.312115","article-title":"Somatic mutations and clonal hematopoiesis: unexpected potential new drivers of age-related cardiovascular disease","volume":"122","author":"Fuster","year":"2018","journal-title":"Circ Res"},{"key":"2023091415161399000_jead168-B29","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1200\/JCO.2005.05.827","article-title":"Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity","volume":"23","author":"Ewer","year":"2005","journal-title":"J Clin Oncol"},{"key":"2023091415161399000_jead168-B30","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1200\/JCO.2005.13.300","article-title":"Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment","volume":"23","author":"Ewer","year":"2005","journal-title":"J Clin Oncol"},{"key":"2023091415161399000_jead168-B31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaccao.2021.08.011","article-title":"Common pathophysiology in cancer, atrial fibrillation, atherosclerosis, and thrombosis: JACC: CardioOncology State-of-the-Art Review","volume":"3","author":"Leiva","year":"2021","journal-title":"JACC CardioOncol"},{"key":"2023091415161399000_jead168-B32","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3390\/jcm9051268","article-title":"Cardiovascular complications of systemic therapy in non-small-cell lung cancer","volume":"9","author":"Zaborowska-Szmit","year":"2020","journal-title":"J Clinical medicine"},{"key":"2023091415161399000_jead168-B33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11912-022-01238-8","article-title":"Radiation-induced cardiovascular disease: mechanisms, prevention, and treatment","volume":"24","author":"Koutroumpakis","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"2023091415161399000_jead168-B34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.iac.2021.12.006","article-title":"Hypersensitivity reactions and immune-related adverse events to immune checkpoint inhibitors: approaches, mechanisms, and models","volume":"42","author":"Park","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"key":"2023091415161399000_jead168-B35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejca.2018.09.014","article-title":"Autoimmune pancreatitis after nivolumab anti-programmed death receptor-1 treatment","volume":"104","author":"Dehghani","year":"2018","journal-title":"Eur J Cancer"},{"key":"2023091415161399000_jead168-B36","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/S1470-2045(18)30457-1","article-title":"Immune checkpoint inhibitors and cardiovascular toxicity","volume":"19","author":"Lyon","year":"2018","journal-title":"Lancet Oncol"},{"key":"2023091415161399000_jead168-B37","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/ejhf.1330","article-title":"Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"\u010celutkien\u0117","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2023091415161399000_jead168-B38","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"2023091415161399000_jead168-B39","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.echo.2015.01.021","article-title":"Intervendor variability of two-dimensional strain using vendor-specific and vendor-independent software","volume":"28","author":"Nagata","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2023091415161399000_jead168-B40","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM197902083000603","article-title":"Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography","volume":"300","author":"Alexander","year":"1979","journal-title":"N Engl J Med"},{"key":"2023091415161399000_jead168-B41","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0002-8703(83)90080-7","article-title":"Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance","volume":"106","author":"Choi","year":"1983","journal-title":"Am Heart J"},{"key":"2023091415161399000_jead168-B42","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10741-020-10028-y","article-title":"The role of cardiac magnetic resonance imaging in the detection and monitoring of cardiotoxicity in patients with breast cancer after treatment: a comprehensive review","volume":"26","author":"Jafari","year":"2021","journal-title":"Heart Fail Rev"},{"key":"2023091415161399000_jead168-B43","doi-asserted-by":"crossref","first-page":"813883","DOI":"10.3389\/fcvm.2022.813883","article-title":"New insights in early detection of anticancer drug-related cardiotoxicity using perfusion and metabolic imaging","volume":"9","author":"Cadour","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2023091415161399000_jead168-B44","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1007\/s12350-019-01671-6","article-title":"Nuclear cardiology in the context of multimodality imaging to detect cardiac toxicity from cancer therapeutics: established and emerging methods","volume":"27","author":"Soufer","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B45","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1053\/j.semnuclmed.2022.02.001","article-title":"Nuclear medicine imaging methods of radiation-induced cardiotoxicity","volume":"52","author":"Polomski","year":"2022","journal-title":"Semin Nucl Med"},{"key":"2023091415161399000_jead168-B46","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"Plana","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B47","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s10554-019-01648-z","article-title":"Assessment of left ventricular function by CMR versus MUGA scans in breast cancer patients receiving trastuzumab: a prospective observational study","volume":"35","author":"Dhir","year":"2019","journal-title":"Int J Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B48","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11897-022-00544-3","article-title":"LVEF by multigated acquisition scan compared to other imaging modalities in cardio-oncology: a systematic review","volume":"19","author":"Printezi","year":"2022","journal-title":"Curr Heart Fail Rep"},{"key":"2023091415161399000_jead168-B49","author":"Odak"},{"key":"2023091415161399000_jead168-B50","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00259-007-0694-9","article-title":"EANM\/ESC Guidelines for radionuclide imaging of cardiac function","volume":"35","author":"Hesse","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023091415161399000_jead168-B51","first-page":"179","article-title":"Gated myocardial perfusion SPECT: basic principles, technical aspects, and clinical applications","volume":"32","author":"Paul","year":"2004","journal-title":"J Nucl Med Technol"},{"key":"2023091415161399000_jead168-B52","first-page":"18144","article-title":"Equilibrium radionuclide angiocardiography for the evaluation of right ventricular ejection fraction in patients with cardiac disorders","volume":"8","author":"Zhao","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"2023091415161399000_jead168-B53","first-page":"942","article-title":"Right and left ventricular volume and ejection fraction by tomographic gated blood-pool scintigraphy","volume":"38","author":"Chin","year":"1997","journal-title":"J Nucl Med"},{"key":"2023091415161399000_jead168-B54","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2967\/jnumed.111.096057","article-title":"Evaluation of left and right ventricular ejection fraction and volumes from gated blood-pool SPECT in patients with dilated cardiomyopathy: comparison with cardiac MRI","volume":"53","author":"Xie","year":"2012","journal-title":"J Nucl Med"},{"key":"2023091415161399000_jead168-B55","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12350-014-0062-7","article-title":"Gated blood pool SPECT: the estimation of right ventricular volume and function is algorithm dependent in a clinical setting","volume":"22","author":"Dercle","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B56","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s12350-014-9915-3","article-title":"Is TOMPOOL (gated blood-pool SPECT processing software) accurate to diagnose right and left ventricular dysfunction in a clinical setting?","volume":"21","author":"Dercle","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B57","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s12350-019-01830-9","article-title":"Equilibrium radionuclide angiography: intra- and inter-observer repeatability and reproducibility in the assessment of cardiac systolic and diastolic function","volume":"28","author":"Sachpekidis","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B58","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1007\/s12350-019-01751-7","article-title":"ACC\/AATS\/AHA\/ASE\/ASNC\/HRS\/SCAI\/SCCT\/SCMR\/STS 2019 appropriate use criteria for multimodality imaging in the assessment of cardiac structure and function in nonvalvular heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons","volume":"26","author":"Doherty","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B59","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0002-9343(87)90212-9","article-title":"Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography","volume":"82","author":"Schwartz","year":"1987","journal-title":"Am J Med"},{"key":"2023091415161399000_jead168-B60","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s12350-019-01823-8","article-title":"New approach for quantification of left ventricular function from low-dose gated bloodpool SPECT: validation and comparison with conventional methods in patients","volume":"28","author":"Liu","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B61","first-page":"1773","article-title":"Planar imaging versus gated blood-pool SPECT for the assessment of ventricular performance: a multicenter study","volume":"42","author":"Groch","year":"2001","journal-title":"J Nucl Med"},{"key":"2023091415161399000_jead168-B62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12968-017-0348-4","article-title":"Accuracy of left ventricular ejection fraction by contemporary multiple gated acquisition scanning in patients with cancer: comparison with cardiovascular magnetic resonance","volume":"19","author":"Huang","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2023091415161399000_jead168-B63","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12968-021-00819-z","article-title":"Normal sex and age-specific parameters in a multi-ethnic population: a cardiovascular magnetic resonance study of the Canadian Alliance for Healthy Hearts and Minds cohort","volume":"24","author":"Luu","year":"2022","journal-title":"J Cardiovasc Magn Reson"},{"key":"2023091415161399000_jead168-B64","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00259-022-05914-6","article-title":"Imaging of heart disease in women: review and case presentation","volume":"50","author":"Mikail","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023091415161399000_jead168-B65","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2967\/jnmt.120.246405","article-title":"SNMMI procedure standard\/EANM guideline for gated equilibrium radionuclide angiography","volume":"48","author":"Farrell","year":"2020","journal-title":"J Nucl Med Technol"},{"key":"2023091415161399000_jead168-B66","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijcard.2015.05.080","article-title":"Long-term outcome and medical radiation exposure in patients hospitalized for cardiovascular disease","volume":"195","author":"Carpeggiani","year":"2015","journal-title":"Int J Cardiol"},{"key":"2023091415161399000_jead168-B67","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jcmg.2009.11.017","article-title":"Low-level ionizing radiation from noninvasive cardiac imaging: can we extrapolate estimated risks from epidemiologic data to the clinical setting?","volume":"3","author":"Laskey","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B68","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2967\/jnumed.115.167205","article-title":"Impact of appropriate use on the estimated radiation risk to men and women undergoing radionuclide myocardial perfusion imaging","volume":"57","author":"Doukky","year":"2016","journal-title":"J Nucl Med"},{"key":"2023091415161399000_jead168-B69","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s12350-019-01619-w","article-title":"Left ventricular ejection fraction determined with the simulation of a very low-dose CZT-SPECT protocol and an additional count-calibration on planar radionuclide angiographic data","volume":"26","author":"Tissot","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B70","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12350-016-0615-z","article-title":"Routine evaluation of left ventricular function using CZT-SPECT, with low injected activities and limited recording times","volume":"25","author":"Claudin","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B71","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12350-015-0367-1","article-title":"Comparison of biventricular ejection fractions using cadmium-zinc-telluride SPECT and planar equilibrium radionuclide angiography","volume":"23","author":"Chen","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B72","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s12350-021-02653-3","article-title":"Comparison of cadmium zinc telluride ECG-gated SPECT equilibrium radionuclide angiocardiography to magnetic resonance imaging to measure right ventricular volumes and ejection fraction in patients with cardiomyopathy","volume":"29","author":"Apert","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B73","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s12350-019-01731-x","article-title":"Left ventricle function assessment using gated first-pass (18)F-FDG PET: validation against equilibrium radionuclide angiography","volume":"28","author":"Bouall\u00e8gue","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B74","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B75","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jcmg.2018.06.003","article-title":"Multi-modality imaging in the assessment of cardiovascular toxicity in the cancer patient","volume":"11","author":"Plana","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B76","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2012.09.035","article-title":"Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy","volume":"61","author":"Thavendiranathan","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B77","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jacc.2020.11.020","article-title":"Strain-guided management of potentially cardiotoxic cancer therapy","volume":"77","author":"Thavendiranathan","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B78","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"2023091415161399000_jead168-B79","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.amjcard.2017.02.008","article-title":"Frequency of left ventricular end-diastolic volume-mediated declines in ejection fraction in patients receiving potentially cardiotoxic cancer treatment","volume":"119","author":"Mel\u00e9ndez","year":"2017","journal-title":"Am J Cardiol"},{"key":"2023091415161399000_jead168-B80","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jacc.2013.01.019","article-title":"Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer","volume":"61","author":"Yl\u00e4nen","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B81","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaccao.2021.04.011","article-title":"Cardiac magnetic resonance in cardio-oncology: advantages, importance of expediency, and considerations to navigate pre-authorization","volume":"3","author":"O\u2019Quinn","year":"2021","journal-title":"JACC CardioOncol"},{"key":"2023091415161399000_jead168-B82","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jcmg.2019.10.016","article-title":"Can quantitative CMR tissue characterization adequately identify cardiotoxicity during chemotherapy? : impact of temporal and observer variability","volume":"13","author":"Altaha","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B83","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/ehjci\/jeu313","article-title":"Accuracy of cardiac CT, radionucleotide and invasive ventriculography, two- and three-dimensional echocardiography, and SPECT for left and right ventricular ejection fraction compared with cardiac MRI: a meta-analysis","volume":"16","author":"Pickett","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B84","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.echo.2013.12.005","article-title":"Analysis of left ventricular volumes and function: a multicenter comparison of cardiac magnetic resonance imaging, cine ventriculography, and unenhanced and contrast-enhanced two-dimensional and three-dimensional echocardiography","volume":"27","author":"Hoffmann","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"2023091415161399000_jead168-B85","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12967-018-1670-9","article-title":"An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline","volume":"16","author":"Sarocchi","year":"2018","journal-title":"J Transl Med"},{"key":"2023091415161399000_jead168-B86","doi-asserted-by":"crossref","first-page":"821267","DOI":"10.3389\/fcvm.2022.821267","article-title":"Coronary atherosclerotic disease and cancer: risk factors and interrelation","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2023091415161399000_jead168-B87","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.thromres.2018.01.003","article-title":"Arterial thrombosis and cancer","volume":"164","author":"Aronson","year":"2018","journal-title":"Thromb Res"},{"key":"2023091415161399000_jead168-B88","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Int Med"},{"key":"2023091415161399000_jead168-B89","first-page":"910","article-title":"Myocardial damage on SPECT imaging among patients treated with radiotherapy for left-sided breast cancer: systematic review with meta-analysis and narrative synthesis","volume":"23","author":"Pak","year":"2018","journal-title":"J BUON"},{"key":"2023091415161399000_jead168-B90","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jaccao.2021.06.003","article-title":"Cardiovascular manifestations from therapeutic radiation: a multidisciplinary expert consensus statement from the International Cardio-Oncology Society","volume":"3","author":"Mitchell","year":"2021","journal-title":"JACC CardioOncol"},{"key":"2023091415161399000_jead168-B91","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jacc.2019.07.006","article-title":"Prevention, diagnosis, and management of radiation-associated cardiac disease: JACC Scientific Expert Panel","volume":"74","author":"Desai","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B92","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/ehjci\/jez219","article-title":"Imaging in ESC clinical guidelines: chronic coronary syndromes","volume":"20","author":"Saraste","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B93","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.radonc.2015.04.009","article-title":"Early detection of radiation-induced heart disease using (99m)Tc-MIBI SPECT gated myocardial perfusion imaging in patients with oesophageal cancer during radiotherapy","volume":"115","author":"Zhang","year":"2015","journal-title":"Radiother Oncol"},{"key":"2023091415161399000_jead168-B94","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"2023091415161399000_jead168-B95","first-page":"286","article-title":"Detection of radiation-induced myocardial damage by technetium-99m sestamibi scintigraphy","volume":"24","author":"Gyenes","year":"1997","journal-title":"Eur J Nucl Med"},{"key":"2023091415161399000_jead168-B96","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0167-8140(02)00133-0","article-title":"Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy","volume":"64","author":"Seddon","year":"2002","journal-title":"Radiother Oncol"},{"key":"2023091415161399000_jead168-B97","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jaccao.2021.06.007","article-title":"Past, present, and future of radiation-induced cardiotoxicity: refinements in targeting, surveillance, and risk stratification","volume":"3","author":"Bergom","year":"2021","journal-title":"JACC CardioOncol"},{"key":"2023091415161399000_jead168-B98","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1200\/JCO.2006.08.6595","article-title":"Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer","volume":"25","author":"Correa","year":"2007","journal-title":"J Clin Oncol"},{"key":"2023091415161399000_jead168-B99","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10549-017-4248-y","article-title":"Early cardiac perfusion defects after left-sided radiation therapy for breast cancer: is there a volume response?","volume":"164","author":"Kaidar-Person","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"2023091415161399000_jead168-B100","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijrobp.2005.01.029","article-title":"The incidence and functional consequences of RT-associated cardiac perfusion defects","volume":"63","author":"Marks","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023091415161399000_jead168-B101","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/jcm11010146","article-title":"Radiation-induced heart disease","volume":"11","author":"Quintero-Martinez","year":"2021","journal-title":"J Clin Med"},{"key":"2023091415161399000_jead168-B102","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/cvr\/cvab053","article-title":"Coronary microcirculation damage in anthracycline cardiotoxicity","volume":"118","author":"Gal\u00e1n-Arriola","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2023091415161399000_jead168-B103","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3390\/jcm11051244","article-title":"The role of vasospasm and microcirculatory dysfunction in fluoropyrimidine-induced ischemic heart disease","volume":"11","author":"Fabin","year":"2022","journal-title":"J Clin Med"},{"key":"2023091415161399000_jead168-B104","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jcmg.2018.11.036","article-title":"Coronary microvascular dysfunction: clinical considerations and noninvasive diagnosis","volume":"13","author":"Schindler","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B105","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.jacc.2018.07.106","article-title":"Coronary physiology beyond coronary flow reserve in microvascular angina: JACC State-of-the-Art Review","volume":"72","author":"Gould","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B106","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1007\/s12350-020-02255-5","article-title":"Coronary vasomotor dysfunction in cancer survivors treated with thoracic irradiation","volume":"28","author":"Groarke","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B107","doi-asserted-by":"crossref","first-page":"20170653","DOI":"10.1259\/bjr.20170653","article-title":"(15)O-H(2)O PET\/CT as a tool for the quantitative assessment of early post-radiotherapy changes of heart perfusion in breast carcinoma patients","volume":"91","author":"\u017byromska","year":"2018","journal-title":"Br J Radiol"},{"key":"2023091415161399000_jead168-B108","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1007\/s12350-021-02825-1","article-title":"Coronary vasomotor dysfunction portends worse outcomes in patients with breast cancer","volume":"29","author":"Divakaran","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B109","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcct.2016.11.003","article-title":"2016 SCCT\/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: a report of the Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology","volume":"11","author":"Hecht","year":"2017","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2023091415161399000_jead168-B110","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jcct.2022.02.002","article-title":"Debates in cardiac CT: the force of data is with CAC\u2014and it\u2019s rock solid","volume":"16","author":"Cainzos-Achirica","year":"2022","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2023091415161399000_jead168-B111","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.jacc.2009.05.071","article-title":"The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk","volume":"54","author":"Chang","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B112","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.jacc.2010.05.057","article-title":"Agreement of visual estimation of coronary artery calcium from low-dose CT attenuation correction scans in hybrid PET\/CT and SPECT\/CT with standard Agatston score","volume":"56","author":"Einstein","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B113","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1007\/s12350-019-01965-9","article-title":"The additive prognostic value of coronary calcium score (CCS) to single photon emission computed tomography myocardial perfusion imaging (SPECT-MPI)-real world data from a single center","volume":"28","author":"Sharma","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B114","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MNM.0000000000001503","article-title":"Accurate measurement of coronary artery calcium in cancer patients using the CT component of PET\/CT scans","volume":"43","author":"McConachie","year":"2022","journal-title":"Nucl Med Commun"},{"key":"2023091415161399000_jead168-B115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcct.2021.09.009","article-title":"Detection of subclinical atherosclerosis from PET-CT in patients with breast cancer","volume":"16","author":"Pope","year":"2022","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2023091415161399000_jead168-B116","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s12350-020-02397-6","article-title":"Reproducibility of global LV function and dyssynchrony parameters derived from phase analysis of gated myocardial perfusion SPECT: a multicenter comparison with core laboratory setting","volume":"29","author":"de Amorim Fernandes","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B117","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13550-018-0445-x","article-title":"Feasibility of biventricular volume and function assessment using first-pass gated (15)O-water PET","volume":"8","author":"Bouall\u00e8gue F","year":"2018","journal-title":"EJNMMI Res"},{"key":"2023091415161399000_jead168-B118","first-page":"805","article-title":"201Tl and 99mTc-MIBI gated SPECT in patients with large perfusion defects and left ventricular dysfunction: comparison with equilibrium radionuclide angiography","volume":"40","author":"Manrique","year":"1999","journal-title":"J Nucl Med"},{"key":"2023091415161399000_jead168-B119","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12350-013-9844-6","article-title":"Gated tomographic radionuclide angiography using cadmium-zinc-telluride detector gamma camera; comparison to traditional gamma cameras","volume":"21","author":"Jensen","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12350-017-0952-6","article-title":"Comparison of CZT SPECT and conventional SPECT for assessment of contractile function, mechanical synchrony and myocardial scar in patients with heart failure","volume":"26","author":"Wu","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B121","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s12350-018-1251-6","article-title":"Assessment of left ventricular ejection fraction with cardiofocal collimators: comparison between IQ-SPECT, planar equilibrium radionuclide angiography, and cardiac magnetic resonance","volume":"26","author":"Pelletier-Galarneau","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B122","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2967\/jnumed.115.168575","article-title":"Left ventricular function assessment using 2 different cadmium-zinc-telluride cameras compared with a \u03b3-camera with cardiofocal collimators: dynamic cardiac phantom study and clinical validation","volume":"57","author":"Bailliez","year":"2016","journal-title":"J Nucl Med"},{"key":"2023091415161399000_jead168-B123","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/ehjci\/jey176","article-title":"Coronary artery calcium and the competing long-term risk of cardiovascular vs. cancer mortality: the CAC Consortium","volume":"20","author":"Whelton","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B124","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/eurheartj\/ehx582","article-title":"Strategies for radiation dose reduction in nuclear cardiology and cardiac computed tomography imaging: a report from the European Association of Cardiovascular Imaging (EACVI), the Cardiovascular Committee of European Association of Nuclear Medicine (EANM), and the European Society of Cardiovascular Radiology (ESCR)","volume":"39","author":"Gimelli","year":"2018","journal-title":"Eur Heart J"},{"key":"2023091415161399000_jead168-B125","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"27","author":"Plana","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"2023091415161399000_jead168-B126","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/euje.2000.0037","article-title":"Dobutamine stress echocardiography identifies anthracycline cardiotoxicity","volume":"1","author":"Cottin","year":"2000","journal-title":"Eur J Echocardiogr"},{"key":"2023091415161399000_jead168-B127","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/pbc.21289","article-title":"Exercise echocardiography reveals subclinical cardiac dysfunction in young adult survivors of childhood acute lymphoblastic leukemia","volume":"49","author":"Jarfelt","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"2023091415161399000_jead168-B128","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijcard.2005.07.029","article-title":"Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy-induced cardiac toxicity","volume":"111","author":"Civelli","year":"2006","journal-title":"Int J Cardiol"},{"key":"2023091415161399000_jead168-B129","doi-asserted-by":"crossref","first-page":"e005505","DOI":"10.1161\/CIRCIMAGING.116.005505","article-title":"Dynamic computed tomography myocardial perfusion imaging: comparison of clinical analysis methods for the detection of vessel-specific ischemia","volume":"10","author":"Rossi","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B130","doi-asserted-by":"crossref","first-page":"jeaa270","DOI":"10.1093\/ehjci\/jeaa270","article-title":"Stress myocardial perfusion with qualitative magnetic resonance and quantitative dynamic computed tomography: comparison of diagnostic performance and incremental value over coronary computed tomography angiography","volume":"8","author":"de Knegt","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B131","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.jacc.2021.08.067","article-title":"Diagnostic performance of dynamic myocardial perfusion imaging using dual-source computed tomography","volume":"78","author":"Kitagawa","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B132","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jcmg.2021.07.021","article-title":"Dynamic myocardial perfusion CT for the detection of hemodynamically significant coronary artery disease","volume":"15","author":"Nous","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B133","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jcmg.2020.10.015","article-title":"High-resolution cardiac magnetic resonance imaging techniques for the identification of coronary microvascular dysfunction","volume":"14","author":"Rahman","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B134","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jcmg.2019.09.006","article-title":"Cardiovascular imaging techniques to assess microvascular dysfunction","volume":"13","author":"Mathew","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B135","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC State-of-the-Art Review","volume":"72","author":"Taqueti","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B136","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jcmg.2022.11.015","article-title":"Second-line myocardial perfusion imaging to detect obstructive stenosis: head-to-head comparison of CMR and PET","volume":"16","author":"Rasmussen","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B137","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/CIRCULATIONAHA.116.025434","article-title":"Risk of heart failure with preserved ejection fraction in older women after contemporary radiotherapy for breast cancer","volume":"135","author":"Saiki","year":"2017","journal-title":"Circulation"},{"key":"2023091415161399000_jead168-B138","first-page":"18","article-title":"Lower endothelium-dependent microvascular function in adult breast cancer patients receiving radiation therapy","volume":"7","author":"Banister","year":"2021","journal-title":"Cardiooncology"},{"key":"2023091415161399000_jead168-B139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"2023091415161399000_jead168-B140","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1136\/heartjnl-2020-318083","article-title":"Cardiotoxicities of novel cancer immunotherapies","volume":"107","author":"Stein-Merlob","year":"2021","journal-title":"Heart"},{"key":"2023091415161399000_jead168-B141","doi-asserted-by":"crossref","first-page":"e13831","DOI":"10.1111\/eci.13831","article-title":"Incidence of immune checkpoint inhibitor mediated cardiovascular toxicity: a systematic review and meta-analysis","volume":"52","author":"Malaty","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"2023091415161399000_jead168-B142","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jcmg.2017.11.036","article-title":"Takotsubo-like syndrome in cancer patients treated with immune checkpoint inhibitors","volume":"11","author":"Ederhy","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B143","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B144","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B145","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.acvd.2021.12.001","article-title":"(18)F-fluorodeoxyglucose positron emission tomography\/computed tomography imaging for the diagnosis of immune checkpoint inhibitor-associated myocarditis","volume":"115","author":"Ederhy","year":"2022","journal-title":"Arch Cardiovasc Dis"},{"key":"2023091415161399000_jead168-B146","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijcard.2013.08.098","article-title":"Determination of optimum periods between onset of suspected acute myocarditis and \u00b9\u2078F-fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory left ventricular myocardium","volume":"169","author":"Ozawa","year":"2013","journal-title":"Int J Cardiol"},{"key":"2023091415161399000_jead168-B147","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.034497","article-title":"Myocarditis in the setting of cancer therapeutics: proposed case definitions for emerging clinical syndromes in cardio-oncology","volume":"140","author":"Bonaca","year":"2019","journal-title":"Circulation"},{"key":"2023091415161399000_jead168-B148","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s12350-016-0616-y","article-title":"Feasibility of FDG-PET in myocarditis: comparison to CMR using integrated PET\/MRI","volume":"25","author":"Nensa","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B149","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","article-title":"Detection of atherosclerotic inflammation by (68)Ga-DOTATATE PET compared to [(18)F]FDG PET imaging","volume":"69","author":"Tarkin","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B150","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s12350-022-03111-4","article-title":"Potential clinical utility of (68)Ga-DOTATATE PET\/CT for detection and response assessment in cardiac sarcoidosis","volume":"30","author":"Lee","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B151","doi-asserted-by":"crossref","first-page":"e003594","DOI":"10.1136\/jitc-2021-003594","article-title":"(68)Ga-DOTATOC PET\/CT to detect immune checkpoint inhibitor-related myocarditis","volume":"9","author":"Boughdad","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2023091415161399000_jead168-B152","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"(68)Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers","volume":"60","author":"Giesel","year":"2019","journal-title":"J Nucl Med"},{"key":"2023091415161399000_jead168-B153","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"(68)Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J Nucl Med"},{"key":"2023091415161399000_jead168-B154","doi-asserted-by":"crossref","first-page":"614997","DOI":"10.3389\/fcvm.2021.614997","article-title":"Early detection of checkpoint inhibitor-associated myocarditis using (68)Ga-FAPI PET\/CT","volume":"8","author":"Finke","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2023091415161399000_jead168-B155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.semnuclmed.2022.08.005","article-title":"Gallium-68 labelled radiopharmaceuticals for imaging inflammatory disorders","volume":"53","author":"Vorster","year":"2023","journal-title":"Semin Nucl Med"},{"key":"2023091415161399000_jead168-B156","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/CIRCRESAHA.120.318539","article-title":"Molecular imaging of inflammation and fibrosis in pressure overload heart failure","volume":"129","author":"Glasenapp","year":"2021","journal-title":"Circ Res"},{"key":"2023091415161399000_jead168-B157","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12410-017-9400-x","article-title":"Novel noninvasive nuclear medicine imaging techniques for cardiac inflammation","volume":"10","author":"Kircher","year":"2017","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"2023091415161399000_jead168-B158","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.7150\/thno.37513","article-title":"CD4(+) And CD8a(+) PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models","volume":"9","author":"Kristensen","year":"2019","journal-title":"Theranostics"},{"key":"2023091415161399000_jead168-B159","doi-asserted-by":"crossref","first-page":"e002261","DOI":"10.1136\/jitc-2020-002261","article-title":"Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancer","volume":"9","author":"Maslov","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2023091415161399000_jead168-B160","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B161","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacc.2009.02.007","article-title":"Cardiovascular magnetic resonance in myocarditis: a JACC White Paper","volume":"53","author":"Friedrich","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B162","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.jcmg.2022.06.014","article-title":"Global circumferential and radial strain among patients with immune checkpoint inhibitor myocarditis","volume":"15","author":"Quinaglia","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B163","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1148\/radiol.211765","article-title":"Cardiac MRI features and prognostic value in immune checkpoint inhibitor-induced myocarditis","volume":"303","author":"Cadour","year":"2022","journal-title":"Radiology"},{"key":"2023091415161399000_jead168-B164","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/eurheartj\/ehaa051","article-title":"Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis","volume":"41","author":"Zhang","year":"2020","journal-title":"Eur Heart J"},{"key":"2023091415161399000_jead168-B165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11886-019-1158-0","article-title":"Assessment of myocarditis: cardiac MR, PET\/CT, or PET\/MR?","volume":"21","author":"Chen","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"2023091415161399000_jead168-B166","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jcmg.2020.03.009","article-title":"Hybrid FDG-PET\/MR or FDG-PET\/CT to detect disease activity in patients with persisting arrhythmias after myocarditis","volume":"14","author":"Palmisano","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B167","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.3390\/jcm11175047","article-title":"Using multiparametric cardiac magnetic resonance to phenotype and differentiate biopsy-proven chronic from healed myocarditis and dilated cardiomyopathy","volume":"11","author":"Krumm","year":"2022","journal-title":"J Clin Med"},{"key":"2023091415161399000_jead168-B168","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.jacc.2016.02.013","article-title":"Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the MyoRacer-Trial","volume":"67","author":"Lurz","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B169","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1536\/ihj.16-225","article-title":"Fulminant myocarditis with prolonged active lymphocytic infiltration after hemodynamic recovery","volume":"58","author":"Tanimura","year":"2017","journal-title":"Int Heart J"},{"key":"2023091415161399000_jead168-B170","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jcmg.2016.02.029","article-title":"Clinical utility of combined FDG-PET\/MR to assess myocardial disease","volume":"10","author":"Abgral","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B171","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2967\/jnumed.114.147744","article-title":"Integrated 18F-FDG PET\/MR imaging in the assessment of cardiac masses: a pilot study","volume":"56","author":"Nensa","year":"2015","journal-title":"J Nucl Med"},{"key":"2023091415161399000_jead168-B172","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1097\/RLU.0000000000001669","article-title":"Initial experience with simultaneous 18F-FDG PET\/MRI in the evaluation of cardiac sarcoidosis and myocarditis","volume":"42","author":"Hanneman","year":"2017","journal-title":"Clin Nucl Med"},{"key":"2023091415161399000_jead168-B173","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcmg.2019.07.018","article-title":"Comprehensive assessment of changes in left ventricular diastolic function with contemporary breast cancer therapy","volume":"13","author":"Upshaw","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B174","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaccao.2020.02.016","article-title":"Longitudinal changes in echocardiographic parameters of cardiac function in pediatric cancer survivors","volume":"2","author":"Border","year":"2020","journal-title":"JACC CardioOncol"},{"key":"2023091415161399000_jead168-B175","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.3390\/jcm10173890","article-title":"Left ventricular diastolic function following anthracycline-based chemotherapy in patients with breast cancer without previous cardiac disease\u2014a meta-analysis","volume":"10","author":"Mincu","year":"2021","journal-title":"J Clin Med"},{"key":"2023091415161399000_jead168-B176","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0735-1097(87)80099-2","article-title":"Alterations in left ventricular diastolic function with doxorubicin therapy","volume":"9","author":"Lee","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B177","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/MNM.0000000000000941","article-title":"Diastolic dysfunction can precede systolic dysfunction on MUGA in cancer patients receiving trastuzumab-based therapy","volume":"40","author":"Klein","year":"2019","journal-title":"Nucl Med Commun"},{"key":"2023091415161399000_jead168-B178","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1067\/mnc.2001.112136","article-title":"Diastolic dysfunction: pathophysiology, clinical features, and assessment with radionuclide methods","volume":"8","author":"Aggarwal","year":"2001","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B179","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s12350-015-0164-x","article-title":"Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)","volume":"23","author":"Reuvekamp","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B180","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s12350-019-01756-2","article-title":"Ventricular peak emptying and filling rates measured by gated tomographic radionuclide angiography using a cadmium-zinc-telluride SPECT camera in chemotherapy-na\u00efve cancer patients","volume":"27","author":"Hansen","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B181","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcmg.2019.02.031","article-title":"CMR in the evaluation of diastolic dysfunction and phenotyping of HFpEF: current role and future perspectives","volume":"13","author":"Chamsi-Pasha","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B182","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-3-662-45074-1_11","volume-title":"Autonomic Innervation of the Heart","author":"Slart","year":"2015"},{"key":"2023091415161399000_jead168-B183","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jcmg.2019.01.042","article-title":"Nuclear imaging of the cardiac sympathetic nervous system: a disease-specific interpretation in heart failure","volume":"13","author":"Zelt","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B184","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/cpf.12419","article-title":"(123) I-MIBG imaging for detection of anthracycline-induced cardiomyopathy","volume":"38","author":"Laursen","year":"2018","journal-title":"Clin Physiol Funct Imaging"},{"key":"2023091415161399000_jead168-B185","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/ehjci\/jeab007","article-title":"The role of myocardial innervation imaging in different clinical scenarios: an expert document of the European Association of Cardiovascular Imaging and Cardiovascular Committee of the European Association of Nuclear Medicine","volume":"22","author":"Gimelli","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B186","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12350-015-0309-y","article-title":"Assessment of late anthracycline-induced cardiotoxicity by (123)I-mIBG cardiac scintigraphy in patients treated during childhood and adolescence","volume":"24","author":"Santos MJ","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B187","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1071-3581(96)90022-7","article-title":"Doxorubicin-induced cardiac neurotoxicity: study with iodine 123-labeled metaiodobenzylguanidine scintigraphy","volume":"3","author":"Lekakis","year":"1996","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B188","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1007\/s12350-021-02610-0","article-title":"MIBG cardiac imaging compared to ejection fraction in evaluation of cardiotoxicity: a systematic review","volume":"29","author":"Arrais","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B189","first-page":"2044","article-title":"Indium-111-antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity","volume":"36","author":"Carri\u00f3","year":"1995","journal-title":"J Nucl Med"},{"key":"2023091415161399000_jead168-B190","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0959-8049(94)00357-B","article-title":"Assessment of anthracycline-related myocardial adrenergic derangement by [123I]metaiodobenzylguanidine scintigraphy","volume":"31a","author":"Vald\u00e9s Olmos","year":"1995","journal-title":"Eur J Cancer"},{"key":"2023091415161399000_jead168-B191","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11886-022-01641-4","article-title":"PET tracers for imaging cardiac function in cardio-oncology","volume":"24","author":"Kelly","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"2023091415161399000_jead168-B192","doi-asserted-by":"crossref","first-page":"e0202302","DOI":"10.1371\/journal.pone.0202302","article-title":"Age- and sex-dependent changes in sympathetic activity of the left ventricular apex assessed by 18F-DOPA PET imaging","volume":"13","author":"Burger","year":"2018","journal-title":"PLoS One"},{"key":"2023091415161399000_jead168-B193","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s00259-017-3728-y","article-title":"Guideline for PET\/CT imaging of neuroendocrine neoplasms with (68)Ga-DOTA-conjugated somatostatin receptor targeting peptides and (18)F-DOPA","volume":"44","author":"Bozkurt","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023091415161399000_jead168-B194","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1007\/s12350-020-02114-3","article-title":"Reproducible quantification of regional sympathetic denervation with [(11)C]meta-hydroxyephedrine PET imaging","volume":"28","author":"Wang","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B195","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ Res"},{"key":"2023091415161399000_jead168-B196","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","article-title":"Metabolic remodelling in heart failure","volume":"15","author":"Bertero","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"2023091415161399000_jead168-B197","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCIMAGING.109.860593","article-title":"Radionuclide imaging of myocardial metabolism","volume":"3","author":"Peterson","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B198","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12265-019-09927-9","article-title":"Metabolic imaging in cardio-oncology","volume":"13","author":"Tong","year":"2020","journal-title":"J Cardiovasc Transl Res"},{"key":"2023091415161399000_jead168-B199","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s12350-015-0136-1","article-title":"Current status of nuclear cardiology in Japan: ongoing efforts to improve clinical standards and to establish evidence","volume":"22","author":"Yoshinaga","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B200","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF03006439","article-title":"Assessment of fatty acid metabolism in taxan-induced myocardial damage with iodine-123 BMIPP SPECT: comparative study with myocardial perfusion, left ventricular function, and histopathological findings","volume":"17","author":"Saito","year":"2003","journal-title":"Ann Nucl Med"},{"key":"2023091415161399000_jead168-B201","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12149-022-01724-w","article-title":"Prediction of cardiac events following concurrent chemoradiation therapy for non-small-cell lung cancer using FDG PET","volume":"36","author":"Cho","year":"2022","journal-title":"Ann Nucl Med"},{"key":"2023091415161399000_jead168-B202","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1007\/s12350-019-01617-y","article-title":"Association between FDG uptake in the right ventricular myocardium and cancer therapy-induced cardiotoxicity","volume":"27","author":"Kim","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B203","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ijrobp.2006.06.007","article-title":"The utility of 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage","volume":"66","author":"Jingu","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023091415161399000_jead168-B204","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/MNM.0b013e328362f824","article-title":"18F-FDG PET\/CT findings of radiotherapy-related myocardial changes in patients with thoracic malignancies","volume":"34","author":"Unal","year":"2013","journal-title":"Nucl Med Commun"},{"key":"2023091415161399000_jead168-B205","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.radonc.2013.07.021","article-title":"Cardiac \u00b9\u2078F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy","volume":"109","author":"Evans","year":"2013","journal-title":"Radiother Oncol"},{"key":"2023091415161399000_jead168-B206","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3390\/jcm9030666","article-title":"Relationship between changes in myocardial F-18 fluorodeoxyglucose uptake and radiation dose after adjuvant three-dimensional conformal radiotherapy in patients with breast cancer","volume":"9","author":"Jo","year":"2020","journal-title":"J Clin Med"},{"key":"2023091415161399000_jead168-B207","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3390\/jcm9072279","article-title":"Myocardial (18)F-FDG uptake pattern for cardiovascular risk stratification in patients undergoing oncologic PET\/CT","volume":"9","author":"Haider","year":"2020","journal-title":"J Clin Med"},{"key":"2023091415161399000_jead168-B208","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B209","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jrr\/rrx076","article-title":"Effect of long fasting on myocardial accumulation in 18F-fluorodeoxyglucose positron emission tomography after chemoradiotherapy for esophageal carcinoma","volume":"59","author":"Ishida","year":"2018","journal-title":"J Radiat Res"},{"key":"2023091415161399000_jead168-B210","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1007\/s12350-021-02852-y","article-title":"Incremental value of (18)F-FDG cardiac PET imaging over dobutamine stress echocardiography in predicting myocardial ischemia in patients with suspected coronary artery disease","volume":"29","author":"Zampella","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B211","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.canlet.2014.02.019","article-title":"Acetate\/acetyl-CoA metabolism associated with cancer fatty acid synthesis: overview and application","volume":"356","author":"Yoshii","year":"2015","journal-title":"Cancer Lett"},{"key":"2023091415161399000_jead168-B212","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1007\/s12350-018-1206-y","article-title":"Repeatable and reproducible measurements of myocardial oxidative metabolism, blood flow and external efficiency using (11)C-acetate PET","volume":"25","author":"Wu","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"2023091415161399000_jead168-B213","doi-asserted-by":"crossref","first-page":"e0169964","DOI":"10.1371\/journal.pone.0169964","article-title":"A novel positron emission tomography (PET) approach to monitor cardiac metabolic pathway remodeling in response to sunitinib malate","volume":"12","author":"O\u2019Farrell","year":"2017","journal-title":"PLoS One"},{"key":"2023091415161399000_jead168-B214","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jacbts.2018.02.003","article-title":"In vivo reactive oxygen species detection with a novel positron emission tomography tracer, (18)F-DHMT, allows for early detection of anthracycline-induced cardiotoxicity in rodents","volume":"3","author":"Boutagy","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"2023091415161399000_jead168-B215","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1021\/acs.molpharmaceut.1c00496","article-title":"A reactivity-based (18)F-labeled probe for PET imaging of oxidative stress in chemotherapy-induced cardiotoxicity","volume":"19","author":"Mota","year":"2022","journal-title":"Mol Pharm"},{"key":"2023091415161399000_jead168-B216","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1038\/s41598-022-10004-6","article-title":"PET imaging of mitochondrial function in acute doxorubicin-induced cardiotoxicity: a proof-of-principle study","volume":"12","author":"Detmer","year":"2022","journal-title":"Sci Rep"},{"key":"2023091415161399000_jead168-B217","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2017.11.024","article-title":"Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction","volume":"71","author":"Thackeray","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023091415161399000_jead168-B218","doi-asserted-by":"crossref","first-page":"20476","DOI":"10.18632\/oncotarget.14730","article-title":"SPECT And PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"2023091415161399000_jead168-B219","first-page":"13. doi: 10.2310\/7290.2014.00049","article-title":"Preclinical validation of 99mTc-annexin A5-128 in experimental autoimmune myocarditis and infective endocarditis: comparison with 99mTc-HYNIC-annexin A5","author":"Benali","year":"2014","journal-title":"Mol Imaging"},{"key":"2023091415161399000_jead168-B220","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2310\/7290.2008.00015","article-title":"Detection of dose response in chronic doxorubicin-mediated cell death with cardiac technetium 99m annexin V single-photon emission computed tomography","volume":"7","author":"Gabrielson","year":"2008","journal-title":"Mol Imaging"},{"key":"2023091415161399000_jead168-B221","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.3390\/ijms22052753","article-title":"Apoptosis imaging in oncology by means of positron emission tomography: a review","volume":"22","author":"Van de Wiele","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2023091415161399000_jead168-B222","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11307-013-0644-9","article-title":"Evaluation of [(18)F]-CP18 as a PET imaging tracer for apoptosis","volume":"15","author":"Su","year":"2013","journal-title":"Mol Imaging Biol"},{"key":"2023091415161399000_jead168-B223","doi-asserted-by":"crossref","first-page":"e001952","DOI":"10.1161\/CIRCIMAGING.114.001952","article-title":"Noninvasive molecular imaging of apoptosis in a mouse model of anthracycline-induced cardiotoxicity","volume":"8","author":"Su","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B224","first-page":"1503","article-title":"Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies","volume":"34","author":"Carri\u00f3","year":"1993","journal-title":"J Nucl Med"},{"key":"2023091415161399000_jead168-B225","first-page":"1965","article-title":"Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer","volume":"31","author":"Estorch","year":"1990","journal-title":"J Nucl Med"},{"key":"2023091415161399000_jead168-B226","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.yjmcc.2015.12.024","article-title":"The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction","volume":"91","author":"Francis Stuart","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"2023091415161399000_jead168-B227","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1093\/eurheartj\/ehac393","article-title":"Phenotyping the hypertensive heart","volume":"43","author":"Tadic","year":"2022","journal-title":"Eur Heart J"},{"key":"2023091415161399000_jead168-B228","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s12551-020-00738-w","article-title":"Imaging tools for assessment of myocardial fibrosis in humans: the need for greater detail","volume":"12","author":"Hassan","year":"2020","journal-title":"Biophys Rev"},{"key":"2023091415161399000_jead168-B229","doi-asserted-by":"crossref","first-page":"10801","DOI":"10.1038\/s41598-017-09790-1","article-title":"Global fibroblast activation throughout the left ventricle but localized fibrosis after myocardial infarction","volume":"7","author":"Nagaraju","year":"2017","journal-title":"Sci Rep"},{"key":"2023091415161399000_jead168-B230","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2967\/jnumed.119.226993","article-title":"Molecular imaging of fibroblast activity after myocardial infarction using a (68)Ga-labeled fibroblast activation protein inhibitor, FAPI-04","volume":"60","author":"Varasteh","year":"2019","journal-title":"J Nucl Med"},{"key":"2023091415161399000_jead168-B231","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1021\/acs.molpharmaceut.2c00551","article-title":"Noninvasive monitoring of reparative fibrosis after myocardial infarction in rats using (68)Ga-FAPI-04 PET\/CT","volume":"19","author":"Qiao","year":"2022","journal-title":"Mol Pharm"},{"key":"2023091415161399000_jead168-B232","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00259-022-05994-4","article-title":"(68)Ga-FAPI PET visualize heart failure: from mechanism to clinic","volume":"50","author":"Song","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023091415161399000_jead168-B233","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/RLU.0000000000003334","article-title":"68Ga-FAPI-04 accumulation in myocardial infarction in a patient with neuroendocrine carcinoma","volume":"45","author":"Zhu","year":"2020","journal-title":"Clin Nucl Med"},{"key":"2023091415161399000_jead168-B234","doi-asserted-by":"crossref","first-page":"e010628","DOI":"10.1161\/CIRCIMAGING.120.010628","article-title":"Relationship between cardiac fibroblast activation protein activity by positron emission tomography and cardiovascular disease","volume":"13","author":"Heckmann","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B235","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00259-022-05962-y","article-title":"Early detection of radiation-induced myocardial damage by [(18)F]AlF-NOTA-FAPI-04 PET\/CT imaging","volume":"50","author":"Wei","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023091415161399000_jead168-B236","doi-asserted-by":"crossref","first-page":"e021931","DOI":"10.1161\/JAHA.121.021931","article-title":"Development and validation of a risk score model for predicting the cardiovascular outcomes after breast cancer therapy: the CHEMO-RADIAT score","volume":"10","author":"Kim","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2023091415161399000_jead168-B237","doi-asserted-by":"crossref","first-page":"e000472","DOI":"10.1161\/JAHA.113.000472","article-title":"Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer","volume":"3","author":"Ezaz","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2023091415161399000_jead168-B238","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/ehf2.12277","article-title":"Native myocardial T1 time can predict development of subsequent anthracycline-induced cardiomyopathy","volume":"5","author":"Muehlberg","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2023091415161399000_jead168-B239","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41824-021-00119-w","article-title":"Combined simultaneous FDG-PET\/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis","volume":"5","author":"Cheung","year":"2021","journal-title":"Eur J Hybrid Imaging"},{"key":"2023091415161399000_jead168-B240","doi-asserted-by":"crossref","first-page":"829553","DOI":"10.3389\/fcvm.2022.829553","article-title":"Multimodality advanced cardiovascular and molecular imaging for early detection and monitoring of cancer therapy-associated cardiotoxicity and the role of artificial intelligence and big data","volume":"9","author":"Kwan","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2023091415161399000_jead168-B241","first-page":"100126","article-title":"Artificial intelligence and imaging: opportunities in cardio-oncology","volume":"15","author":"Madan","year":"2022","journal-title":"Am Heart J Plus"},{"key":"2023091415161399000_jead168-B242","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jcmg.2017.07.024","article-title":"Prognostic value of combined clinical and myocardial perfusion imaging data using machine learning","volume":"11","author":"Betancur","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023091415161399000_jead168-B243","doi-asserted-by":"crossref","first-page":"17787","DOI":"10.1038\/srep17787","article-title":"Deciphering genomic underpinnings of quantitative MRI-based radiomic phenotypes of invasive breast carcinoma","volume":"5","author":"Zhu","year":"2015","journal-title":"Sci Rep"},{"key":"2023091415161399000_jead168-B244","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12859-017-1798-2","article-title":"Unsupervised deep learning reveals prognostically relevant subtypes of glioblastoma","volume":"18","author":"Young","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"2023091415161399000_jead168-B245","doi-asserted-by":"crossref","first-page":"e23421","DOI":"10.7554\/eLife.23421","article-title":"Defining the biological basis of radiomic phenotypes in lung cancer","volume":"6","author":"Grossmann","year":"2017","journal-title":"Elife"},{"key":"2023091415161399000_jead168-B246","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2967\/jnumed.118.220137","article-title":"Precision cardio-oncology","volume":"60","author":"Dreyfuss","year":"2019","journal-title":"J Nucl Med"},{"key":"2023091415161399000_jead168-B247","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2967\/jnumed.120.251512","article-title":"Somatostatin receptor imaging and theranostics: current practice and future prospects","volume":"62","author":"Park","year":"2021","journal-title":"J Nucl Med"},{"key":"2023091415161399000_jead168-B248","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1200\/JCO.2005.03.8448","article-title":"Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer","volume":"24","author":"Perik","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jead168\/50965846\/jead168.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/24\/9\/1129\/51554280\/jead168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/24\/9\/1129\/51554280\/jead168.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:54:51Z","timestamp":1694728491000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/24\/9\/1129\/7226632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,19]]},"references-count":248,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,7,19]]},"published-print":{"date-parts":[[2023,8,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jead168","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,7,19]]}}}